Delivery Order SPE2DB22D1106-SPE2DB24FFKH7

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,574.56 firm fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,336.25 firm fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,638.72, is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,968.78 firm fixed price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,645.69 firm fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,711.84 Firm Fixed Price Delivery Order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication, with a ceiling value of $17,850.20 and a period of performance through January 30, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,712.54, is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. The contract is a firm fixed price delivery order with a completion date of March 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award is a delivery order with a ceiling value of $31,406.85 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a period of performance through May 5, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. The contract has a ceiling value of $18,532.35 and runs through July 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999,...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFKH7
    Delivery Order

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. The contract has a ceiling value of $16,701.98 and an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/28/24, 9:38 AM